Lindbrook Capital, LLC Gilead Sciences, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 4,182 shares of GILD stock, worth $377,174. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,182

Previous 3,800 10.05%

Holding current value

$377,174

Previous $260,000 34.62%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$66.59 - $83.99 $25,437 - $32,084	382 Added 10.05%	4,182 $350,000
Q2 2024 Jul 31, 2024	BUY	$63.15 - $72.88 $58,666 - $67,705	929 Added 32.36%	3,800 $260,000
Q1 2024 Apr 25, 2024	SELL	$71.58 - $87.29 $28,488 - $34,741	-398 Reduced 12.17%	2,871 $210,000
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $64,697 - $73,368	883 Added 37.01%	3,269 $264,000
Q3 2023 Oct 25, 2023	SELL	$73.94 - $80.67 $16,414 - $17,908	-222 Reduced 8.51%	2,386 $178,000
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $14,821 - $16,906	195 Added 8.08%	2,608 $200,000
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $438,270 - $499,325	-5,669 Reduced 70.14%	2,413 $200,000
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $418,603 - $600,969	6,717 Added 492.09%	8,082 $0
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $13,456 - $15,370	226 Added 19.84%	1,365 $84,000
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $353,881 - $398,576	-6,131 Reduced 84.33%	1,139 $70,000
Q1 2022 Apr 21, 2022	BUY	$57.92 - $72.58 $17,549 - $21,991	303 Added 4.35%	7,270 $432,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $2,205 - $2,503	34 Added 0.49%	6,967 $506,000
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $1,895 - $2,044	28 Added 0.41%	6,933 $484,000
Q2 2021 Jul 27, 2021	SELL	$63.47 - $69.35 $2,284 - $2,496	-36 Reduced 0.52%	6,905 $475,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $58,560 - $66,816	976 Added 16.36%	6,941 $449,000
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $963 - $1,097	17 Added 0.29%	5,965 $348,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $37,197 - $46,769	-599 Reduced 9.15%	5,948 $376,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $7,595 - $8,820	-105 Reduced 1.58%	6,547 $504,000
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $17,411 - $22,301	278 Added 4.36%	6,652 $497,000
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $1,848 - $2,033	-30 Reduced 0.47%	6,374 $414,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $120,581 - $133,101	-1,929 Reduced 23.15%	6,404 $406,000
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $83,153 - $93,246	1,344 Added 19.23%	8,333 $562,000
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $8,316 - $9,316	133 Added 1.94%	6,989 $454,000
Q4 2018 Feb 07, 2019	BUY	$60.54 - $79.0 $415,062 - $541,624	6,856 New	6,856 $428,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Gilead Sciences, Inc. Transaction History